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ABSTRACT
Background Primary lymphoedema describes a chronic,
frequently progressive, failure of lymphatic drainage. This
disorder is frequently genetic in origin, and
a multigenerational family in which eight individuals
developed postnatal lymphoedema of all four limbs was
ascertained from the joint Lymphoedema/Genetic clinic
at St George’s Hospital.
Methods Linkage analysis was used to determine
a locus, and exome sequencing was employed to look for
causative variants.
Results Linkage analysis revealed cosegregation of
a 16.1 Mb haplotype on chromosome 1q42 that
contained 173 known or predicted genes. Whole exome
sequencing in a single affected individual was
undertaken, and the search for the causative variant was
focused to within the linkage interval. This approach
revealed two novel non-synonymous single nucleotide
substitutions within the chromosome 1 locus, in NVL and
GJC2. NVL and GJC2 were sequenced in an additional
cohort of individuals with a similar phenotype and non-
synonymous variants were found in GJC2 in four
additional families.
Conclusion This report demonstrates the power of
exome sequencing efficiently applied to a traditional
positional cloning pipeline in disease gene discovery, and
suggests that the phenotype produced by GJC2
mutations is predominantly one of 4 limb lymphoedema.
INTRODUCTION
The accumulation of protein-rich ﬂuid in the
interstitial spaces results from an anatomical or
functional defect in the lymphatic vessels and can
occur as a non-syndromic Mendelian condition or
as part of a more complex, syndromic disorder.1
Primary lymphoedema most commonly affects the
lower limbs, but other body parts (upper limbs,
face, and genitalia) can also be affected. Lympho-
scintigraphy occasionally reveals lymphatic abnor-
malities in the upper limbs in individuals
presenting with oedema of the lower limbs.1
However, individuals with clinical signs of primary
lymphoedema in all four limbs are not commonly
seen in the lymphoedema clinic. Connell et al2
reported 23 cases out of a cohort of 333 probands
with late onset multisegmental primary lymphoe-
dema affecting other body parts in addition to the
lower limbs. A proportion of these had an auto-
somal dominant family history (F Connell, personal
communication, 2010).
As with many other Mendelian traits, positional
cloning by linkage mapping has proved to be
a powerful approach in the identiﬁcation of genes
underlying primary lymphoedema. To date ﬁve
genes have been shown to be mutated in disorders
where lymphoedema is the major feature. Three
genes were identiﬁed by linkage based positional
cloning; FLT4 (VEGFR3) in Milroy disease,2e5
FOXC2 in lymphoedema distichiasis syndrome 6 7
and SOX18 in the rare hypotrichosise
lymphoedemaetelangiectasia syndrome.8 In addi-
tion, the human mutation of CCBE1 was identiﬁed
in generalised lymphatic dysplasia/Hennekam
syndrome 9 10 because loss of function defects in
ccbe1 in the zebra ﬁsh mutant ’full of ﬂuid’ (fof)
highlighted the role of the CCBE1 protein product
in lymphangiogenesis.11 Most recently, Ferrell et al
identiﬁed mutations in GJC2 after differential
transcript expression analysis highlighted a poten-
tial role of this gene in lymphoedema.12
The experimental route from linkage interval to
causative mutation has traditionally been by
Sanger sequencing of the coding regions and asso-
ciated splice sites of the genes located within the
delimiting recombination boundaries. While this
approach has proved successful it is often limited
by the size of the region of interest and the number
of genes within it. Sequencing of more than
a handful of genes can become a costly and time
consuming process. However, recent developments
in high throughput second generation sequencing
and hybrid capture techniques13 now offer a more
cost effective approach to this sequencing phase.
Several recent investigations have shown the utility
of customisable capture arrays for sequencing genes
located within linkage intervals.14e17 However,
improvements in capture efﬁciency with ‘in solu-
tion’ methods combined with increases in sequence
yield now make whole exome sequencing an
affordable alternative.
We present a large, multigenerational pedigree
(ﬁgure 1) in which four limb primary lymphoedema
is segregating in an autosomal dominant manner.
Linkage analysis combined with whole exome
sequencing rapidly identiﬁed two candidate genes
with potential pathogenic variants co-segregating
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with the disease status. Subsequent analysis of these two genes
in a cohort of additional individuals with primary lymphoedema
conﬁrmed that the identiﬁed defect in GJC2 underlies four limb
lymphoedema in family I, and also provides evidence that
mutations in GJC2 contribute to a signiﬁcant proportion of
autosomal dominant lymphoedema cases.
METHODS
Patients and controls
Patients were ascertained through the joint dermatology/
genetics lymphoedema clinic at St George’s Hospital, as part of
the ongoing UKCRN registered study into the genetic causes of
primary lymphoedema. There is current ethical permission for
this project. Patients were clinically assessed and where possible
lymphoscintigram and venous duplex scans were performed.
Use of a diagnostic algorithm18 allowed grouping of patients by
phenotype. Initially, two probands from families I and II with
lymphoedema of all four limbs and extensive positive family
histories were identiﬁed for molecular analysis. Subsequently,
other patients, from whom DNA samples were available, with
similar and different primary lymphoedema phenotypes were
studied (see Results for further details). All variants identiﬁed
were assessed in a cohort of 150 control individuals of European
ancestry.
SNP chip array and linkage analysis
DNA was extracted from peripheral blood using a standard
chloroform ethanol procedure. Single nucleotide polymorphism
(SNP) genotyping was undertaken on 12 individuals from family
I. Processing of SNP microarrays (Illumina, Human Linkage-12
panel with 6090 SNP markers) was performed according to the
manufacturer ’s protocol. All genotype calls were checked for
Mendelian inconsistencies and parametric LOD (logarithm of
odds) scores calculated with MERLIN19 using an autosomal
dominant model, 99% penetrance and 1% phenocopy rate.
Exome sequencing
Genomic DNA from the proband of family I was fragmented
and enriched for exomic sequences with the Agilent SureSelect
Whole Exome hybrid capture. The resulting enriched sequence
library was sequenced with 76 bp paired end reads across two
lanes of Illumina GaIIx ﬂowcell (v2 chemistry). The sequence
reads were aligned to the reference genome (hg18) with the
Novoalign aligner. Duplicate reads, resulting from PCR clonality
or optical duplicates, and reads mapping to multiple locations
were excluded from downstream analysis. Single nucleotide
substitutions and small insertion deletions were identiﬁed and
quality ﬁltered within the SamTools software package.20
Filtering of variants for novelty was performed by comparison to
dbSNP131, 1000 Genomes SNP calls (March 2010).
PCR and Sanger sequencing
Primers were designed to cover exonic and intronic ﬂanking
sequences for NVL and GJC2 (primer sequences and PCR condi-
tions are available upon request). PCR products were sequenced
using BigDye Terminator v3.1 and an ABI 31303l Genetic
Analyser. The sequencing traces were visually inspected in Finch
TV v1.4 (Geospiza, Inc, Seattle, WA, USA) and compared to wild
type reference sequence inCLCSequenceViewer6.4 (CLCbioA/S).
RESULTS
Clinical assessment of four limb lymphoedema in family I
Family I
Seven affected members of this family along with six at-risk
relatives were clinically examined by one of the authors (GB).
The inheritance pattern was consistent with autosomal domi-
nance and there was no evidence of non-penetrance. Expression
was variable, ranging from mild, below knee swelling to severe,
four limb swelling. Age of initial presentation of oedema ranged
from 8e14 years. The two individuals in the family with the
most severe swelling had suffered multiple episodes of cellulitis.
One individual had undergone isotope lymphoscintigraphy
which was reported to show poor uptake in all four limbs,
suggestive of distal hypoplasia. No members of this family had
vein scan results available; however, one individual did report
removal of the long saphenous vein in his 20s.
Linkage analysis
Genotyping of 6000 SNPs distributed throughout the genome
(Illumina Human Linkage 12) in eight affected individuals and
four unaffected relatives in family I (ﬁgure 1) revealed a 16.1 Mb
chromosomal region, delimited by markers rs10494988 and
rs1043909, co-segregating with the disease status. Linkage
analysis of these data performed with Merlin, under a model of
autosomal dominant inheritance with 99% penetrance and a 1%
phenocopy rate, generated a maximum LOD of 2.94 within the
chromosome 1 region.
Sequencing
The putative 16.1 Mb region on chromosome 1 contains 173
known or predicted genes. A strategy of whole exome sequencing
by hybrid capture and second generation sequencing was
employed. Sequencingof theCCDSdeﬁned exomewasundertaken
in a single affected individual from family I (individual III.10,ﬁgure
1). The efﬁciency of the hybrid capture was 73.4% with 51494434
of the 70164176 uniquelymapped sequence reads originating from
the targeted exomic regions (75.1% to the targeted regions
6150 bp). This level of capture efﬁciency and sequence generation
resulted in a mean coverage of the CCDS deﬁned exome of 973,
with 91.7% of CCDS bases covered by at least 10 reads.Within the
chromosome 1 linkage interval (rs10494988 to rs1043909), 20
candidate heterozygous non-synonymous variantswere identiﬁed,
of which 18 were excluded based on their presence in genomic
variant databases. This left just two candidate heterozygous vari-
ants, inNVL (c.2236G>A; p.Val746Met), andGJC2 (c.143C>T; p.
Ser48Leu). Subsequent genotyping of both variants in the entire
family revealed that both variants co-segregated with the disease
status. Neither change was seen in 150 control individuals.
Mutation validation
Initial investigation to establish which of the variants was
pathogenic was undertaken by Sanger sequencing of coding
exons and associated splice sites of NVL and GJC2 in a second
family (family II, ﬁgure 2) also consistent with linkage to the
same chromosome 1 region. Interestingly, the two variants
Figure 1 Family I, in which the initial linkage analysis was performed.
Novel variants in NVL (c.2236G>A; pVal746Met), and GJC2 (c.143C>T;
p.Ser48Leu) were observed.
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identiﬁed in family I were also observed and shown to co-
segregate in this family. While clinical family histories did not
suggest that the two families were closely related, interrogation
of the SNP genotypes generated for linkage mapping across the
chr 1q42.1 linkage interval (eight SNPs) suggested the presence
of a shared ancestral haplotype across this region in the two
families (data not shown).
Further sequencing of NVL and GJC2 was undertaken in
a cohort of 19 unrelated individuals with primary lymphoedema
and revealed three further families with variants in GJC2 but no
additional variants in NVL. The variants in GJC2 observed in
this cohort comprised two proposita with the same Ser48Leu
variant that was identiﬁed in families I and II, and a single
occurrence of a non-synonymous variant (c.629T>G,
p.Met210Arg). This variant was not observed in 150 control
individuals. These results strongly suggest that GJC2 is the site
of mutations underlying the autosomal dominant lymphoedema
phenotype linked to this locus.
Clinical assessment of GJC2 mutation positive individuals
Family II
Four affected individuals from this family (ﬁgure 2), were clini-
cally examined. They all had four limb lymphoedema, with one
having additional involvement of the face and genitals. The
most severely affected individual reported multiple episodes of
cellulitis. The age of initial onset of oedema was variable
but predominantly in childhood. In one individual, leg swelling
developed in childhood but arm swelling was not noted until the
age of 30 years. Lymph scans were performed in three individ-
uals. All scans revealed that, although lymph channels could be
clearly imaged, uptake of tracer in the lymph nodes at 2 h post-
injection was notably impaired in all four limbs. Speciﬁcally,
lymph transport over 2 h was substantially reduced. One
member of the family had undergone venous duplex scans of the
lower limbs. This revealed incompetent great saphenous veins
bilaterally.
Family III
Two members of this family (father and daughter) were exam-
ined in clinic. A history of lymphoedema in several other family
members was reported, consistent with autosomal dominant
inheritance. Both members of this family who were examined
had lower limb lymphoedema only. In the younger of the two
family members the oedema signiﬁcantly worsened at the age of
13 years, but there is a history of onset before this age, possibly
at birth. Her father did not recognise he was affected until
examined in clinic and therefore the true age of onset is not
known. He had, however, suffered with varicose veins from
a young age. Clinically the hands were not oedematous so only
lower limb lymph scans were requested. These showed relatively
normal main tract ﬁlling but with notably impaired uptake in
the groin nodes at 2 h, consistent with distal hypoplasia of the
lymphatics. Vein scans performed on both individuals revealed
identical results, with pronounced incompetence of the great
saphenous vein bilaterally.
Family IV
This Somalian family had two sisters affected by swelling to
the knees bilaterally. Although their parents were distant
cousins, their mother and maternal aunt were also reported to
be affecteddagain consistent with autosomal dominant
inheritance. The age of onset in both cases was 12 years.
Results of four limb lymph scans and duplex vein scans are
awaited.
Family V
This family showed clear autosomal dominant inheritance with
four affected members in three generations. The age of onset
was between the age of 4e40 years. Multiple episodes of cellu-
litis were a feature. Lymphoscintigraphy showed impaired
drainage in all four limbs and a venous duplex scan revealed
incompetence of the great saphenous vein bilaterally.
Details of the GJC2 mutations, and summary of the clinical
details, are given in table 1.
Figure 2 Family II in which the same two novel variants identified
in family I (NVL (c.2236G>A; pVal746Met), and GJC2 (c.143C>T;
p.Ser48Leu)) were also identified.
Table 1 Clinical, lymphoscintigraphic, and venous parameters known for those patients with a mutation in GJC2
Family I Family II Family III Family IV Family V
Variant identified 143C>T (p.S48L) 143C>T (p.S48L) 143C>T (p.S48L) 143C>T (p.S48L) 629C>G (p.M210R)
Number of affected 8 4 2 2 4
Age of onset (years) 8e14 Birth to 10 0 to adult 12 4e40
Limbs affected Bilateral lower limb, 4 limb 4 limb, one with face and
genital swelling
Bilateral lower limb Bilateral lower limb 4 limb oedema
Varicose/incompetent veins One individual One individual Father Venous duplex awaited Yes, incompetent vein
Other associated abnormalities None None None None None
Lymphoscintigraphy Poor uptake at 2 h. Distal
hypoplasia
Poor uptake at 2 h. Distal
hypoplasia
Poor uptake at 2 h. Distal
hypoplasia
Awaited Poor uptake at 2 h. Distal
hypoplasia
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DISCUSSION
This study clearly demonstrates the power and efﬁciency of the
combination of linkage analysis with whole exome sequencing in
the identiﬁcation of causative genes in Mendelian phenotypes.
Moving from the successful identiﬁcation of the co-segregating
chromosome 1 interval containing 173 genes to the identiﬁcation
of the causative mutation would previously have been prohibi-
tively costly and time consuming, beyond Sanger sequencing of
a small number of potential candidate genes. Recent develop-
ments in high throughput sequencing have provided a novel
solution to such challenges. The approach undertaken here
enabled rapid and cost effective sequencing of the entire exome,
but interrogation of the generated sequence data was restricted to
genes located within the linkage interval. This initial sequencing
led to a shortlist of two potential variants which could not be
differentiated within family I, but ultimately this was resolved
through the identiﬁcation of additional mutations in GJC2 in
a cohort of unrelated lymphoedema cases. It is also notable that
computational prediction of potential functional consequences of
the two variants using the SIFT algorithm was of no beneﬁt in
this scenario. The results predicted the Val746Met variant inNVL
to be damaging whereas the Ser48Leu variant in GJC2 was
proposed to be tolerated. The use of computational predictors of
the functional consequences of variants with algorithms
including SIFTand PolyPhen have been proposed as a method of
ﬁltering variants for potential pathogenicity in high throughput
sequencing studies.21 However, the experiences in our study and
those of Ng et al22 suggest that the interpretation of computa-
tional predictions must be handled with appropriate caution.
Ultimately the success of the linkage and second generation
sequencing approach in this study is clear, with the identiﬁcation
of GJC2 as the site of mutation in primary lymphoedema. This
ﬁnding conﬁrms the investigations of Ferrell et al,12 who used the
results from a differential gene expression study23 to identify
candidate genes in lymphoedema on the basis of greater expres-
sion in lymphatic endothelial cells (LECs) compared to blood
endothelial cells (BECs). GJC2was highlighted by their approach
as its expression levels were ﬁve times higher in LECs than BECs.23
Subsequent sequencing of this gene in a large cohort (160
probands) of lymphoedema patients revealed six pathogenic
mutations within the coding region of GJC2.12
From a clinical viewpoint, individuals identiﬁed with hetero-
zygous mutations in GJC2 characteristically presented with four
limb lymphoedema, although some affected individuals only
exhibited bilateral lower limb oedema. The age of onset was
variable, both between and within families, ranging from birth
to 40 years of age. It is possible that those affected with only
lower limb lymphoedema may develop upper limb swelling at
a later date. The upper limbs are always less severely affected
and need to be examined speciﬁcally for lymphoedema. In those
individuals subjected to lymphoscintigraphy, functional rather
than anatomical abnormalities have been demonstrated. Thus,
lymph drainage routes as seen on images looked normal but
quantiﬁcation revealed unequivocally reduced lymph transport
as measured by ilio-inguinal/axillary node uptake over 2 h. This
was a consistent ﬁnding in all ﬁve lymphoscintograms thus far
undertaken. Furthermore, reduced axillary lymph node uptake
and impaired upper limb transport was evident in one individual
without obvious hand oedema. Therefore, phenotyping for this
category of lymphoedema requires a careful history and exami-
nation of hand oedema, as well as upper limb lymphoscintig-
raphy with quantiﬁcation of lymph transport. The mechanism
for lymph drainage failure needs further investigation.
Most of the affected individuals (particularly the adults)
suffered with truncal varicose veins or had evidence of reﬂux of
the great saphenous vein on duplex ultrasound examination.
A true venous phenotype needs conﬁrmation, but the ﬁndings
support the view that genetic forms of lower limb lymphoe-
dema are often associated with venous valve failure, as has been
demonstrated with VEGFR3 and FOXC2 mutations.24 25 Venous
reﬂux in adults may contribute to lower limb but not upper limb
oedema, because of increased ﬂuid ﬁltration from venous
hypertension. Greater gravitational stress (dependency) through
higher venous pressures may explain increased expression of
lower limb lymphoedema, with vulnerable upper limb drainage
relatively protected from dependency.
Mutations in GJC2 have previously been described in the
literature as the cause of autosomal recessively inherited Peli-
zaeuseMerzbacher-like disease (PMLD), which is a rare hypo-
myelinating disorder of the central nervous system. Uhlenberg
et al26 noted that their heterozygous individuals had no neuro-
logical symptoms. PMLD is a very rare condition, so it is possible
that mild lymphoedema could have been present in the parents,
but it seems improbable that this would have passed unnoticed
in all heterozygotes. It is more likely that the mechanism of
action is different in the two conditions. Examples of genes
causing different diseases where there is dominant or recessive
inheritance of mutations include ROR2 in brachydactyly and
Robinow syndrome27e29 and BSCL2 in spastic paraplegia type
17 and generalised lipodystrophy type 2.30 31 In both these cases
there appears to be a loss of function in the recessive conditions
and a gain of function, or interference with the wild type
product when there is dominant inheritance.
There is not yet sufﬁcient evidence on the functional effects of
GJC2 mutations in lymphoedema to know whether the same
scenario applies here vis a vis PMLD. It is of interest that there
appear to be at least two mechanisms for the effect of mutations
in PMLDdnamely, a loss of hemichannel function, or in some
cases a dysfunction.32 33 To complicate the picture further,
a mutation identiﬁed by Ferrell et al as causative in lymphoe-
dema, p.Gly149Ser, is also reported as being causative for
PMLD.33 A mechanism to explain this is currently difﬁcult,
especially as this mutation is one of those proposed to be loss of
function of hemichannels in PMLD rather than dysfunction.33
We conclude that mutations in GJC2 appear to be a signiﬁcant
cause of autosomal dominantly inherited four limb and bilateral
lower limb lymphoedema. Further work will be required to
determine the molecular mechanisms by which GJC2 contrib-
utes to the formation and maintenance of the lymphatic
system.
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